$13.97
2.03%
Nasdaq, Sep 17, 04:00 pm EDT. Closed.
ISIN
US05356F1057
Symbol
AVAH

Aveanna Healthcare Holdings Inc Target price 2026 - Analyst rating & recommendation

Aveanna Healthcare Holdings Inc Classifications & Recommendation

Buy
76%
Hold
24%

Aveanna Healthcare Holdings Inc Price Target

Target Price $14.28
Price $13.97
Potential
Number of Estimates 12
12 Analysts have issued a price target Aveanna Healthcare Holdings Inc 2027 . The average Aveanna Healthcare Holdings Inc target price is $14.28. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 17 analysts: 13 Analysts recommend Aveanna Healthcare Holdings Inc to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Aveanna Healthcare Holdings Inc stock has an average upside potential 2027 of . Most analysts recommend the Aveanna Healthcare Holdings Inc stock at Purchase.

Sales and Margin forecast 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Jan '26 2027
Estimates
Revenue Billion $ 2.43 2.95
21.03%
EBITDA Margin 11.13% 13.67%
22.82%
Net Margin 9.25% 6.83%
26.15%

13 Analysts have issued a sales forecast Aveanna Healthcare Holdings Inc 2027 . The average Aveanna Healthcare Holdings Inc sales estimate is

$2.9b
unlock
. This is
13.15% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.1b 18.45%
unlock
, the lowest is
$2.7b 5.50%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 $2.4b
2027
$2.9b 21.03%
unlock
2028
$3.1b 5.40%
unlock

13 Analysts have issued an Aveanna Healthcare Holdings Inc EBITDA forecast 2027. The average Aveanna Healthcare Holdings Inc EBITDA estimate is

$403m
unlock
. This is
37.45% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$432m 47.38%
unlock
, the lowest is
$354m 20.76%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 $271m
2027
$403m 48.69%
unlock
2028
$427m 5.98%
unlock

EBITDA Margin

2026 11.13%
2027
13.67% 22.82%
unlock
2028
13.75% 0.59%
unlock

13 Aveanna Healthcare Holdings Inc Analysts have issued a net profit forecast 2027. The average Aveanna Healthcare Holdings Inc net profit estimate is

$201m
unlock
. This is
26.85% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$220m 19.97%
unlock
, the lowest is
$175m 36.20%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 $225m
2027
$201m 10.68%
unlock
2028
$209m 3.79%
unlock

Net Margin

2026 9.25%
2027
6.83% 26.15%
unlock
2028
6.72% 1.61%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Jan '26 2027
Estimates
Earnings Per Share $ 1.05 0.92
12.38%
P/E 15.48
EV/Sales 1.52

13 Analysts have issued a Aveanna Healthcare Holdings Inc forecast for earnings per share. The average Aveanna Healthcare Holdings Inc EPS is

$0.92
unlock
. This is
25.20% lower
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
$1.01 17.89%
unlock
, the lowest is
$0.80 34.96%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 $1.05
2027
$0.92 12.38%
unlock
2028
$0.96 4.35%
unlock

P/E ratio

Current 11.36 89.23%
2027
15.48 33.52%
unlock
2028
14.91 3.68%
unlock

Based on analysts' sales estimates for 2027, the Aveanna Healthcare Holdings Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.70 18.88%
2027
1.52 11.59%
unlock
2028
1.44 5.12%
unlock

P/S ratio

Current 1.17 44.71%
2027
1.06 11.61%
unlock
2028
1.00 5.13%
unlock

Current Aveanna Healthcare Holdings Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JP Morgan
Locked
Locked
Locked Sep 14 2026
Barclays
Locked
Locked
Locked Aug 28 2026
RBC Capital
Locked
Locked
Locked Aug 24 2026
Truist Securities
Locked
Locked
Locked Aug 24 2026
BMO Capital
Locked
Locked
Locked Aug 14 2026
Raymond James
Locked
Locked
Locked Aug 14 2026
UBS
Locked
Locked
Locked Aug 14 2026
Analyst Rating Date
Locked
JP Morgan:
Locked
Locked
Sep 14 2026
Locked
Barclays:
Locked
Locked
Aug 28 2026
Locked
RBC Capital:
Locked
Locked
Aug 24 2026
Locked
Truist Securities:
Locked
Locked
Aug 24 2026
Locked
BMO Capital:
Locked
Locked
Aug 14 2026
Locked
Raymond James:
Locked
Locked
Aug 14 2026
Locked
UBS:
Locked
Locked
Aug 14 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today